90 related articles for article (PubMed ID: 4387192)
1. [Considerations on the histidine-decarboxylase inhibitor (554 L) in the treatment of pruriginous disease].
Abry M
Lyon Med; 1967 Mar; 217(10):753-6. PubMed ID: 4387192
[No Abstract] [Full Text] [Related]
2. [Influence of histidine decarboxylase inhibitor 554 L (Hypostamine) on the behavior of certain indices of histamine and serotonin metabolism].
Czernielewski A; Pakszys W; Wranicz A; Matyjewska H
Przegl Dermatol; 1967; 54(1):17-22. PubMed ID: 4382888
[No Abstract] [Full Text] [Related]
3. Treatment of adjuvant arthritis in rats with the histidine decarboxylase inhibitor hypostamine.
Pelczarska A
J Pharm Pharmacol; 1969 Oct; 21(10):692-3. PubMed ID: 4390614
[No Abstract] [Full Text] [Related]
4. [Preliminary clinical trials of a new histidine-decarboxylase inhibitor in the therapy of prurigo].
Rossi A; De Luca M
Arch Anat Microsc Morphol Exp; 1970; 59(2):201-4. PubMed ID: 4194817
[No Abstract] [Full Text] [Related]
5. [New derivatives with presumed histidine decarboxylase inhibitory action].
Giannini M; Fedi M
Boll Chim Farm; 1970 Jan; 109(1):39-47. PubMed ID: 4393826
[No Abstract] [Full Text] [Related]
6. [Therapeutic application of an inhibitor of histidine-decarboxylase].
THIERS H; MOULIN G; ROUHANI A
Lyon Med; 1963 Mar; 209():689-94. PubMed ID: 13980982
[No Abstract] [Full Text] [Related]
7. [Biological study of the effects of a histidine decarboxylase inhibitor (L 554) on histidine metabolism].
Cotte J; Collombel C; Carron R
Pediatrie; 1966; 21(7):841-3. PubMed ID: 4382608
[No Abstract] [Full Text] [Related]
8. [Histidine decarboxylase inhibitors].
Kasztreiner E; Szilágyi G; Szakályné KJ; Huszti Z; Kürti M
Acta Pharm Hung; 1973 Jul; 43(3):121-5. PubMed ID: 4127039
[No Abstract] [Full Text] [Related]
9. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
Greaves MW
Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
[No Abstract] [Full Text] [Related]
10. The effect of the histidine decarboxylase inhibitor brocresine (NSD-1055) on gastric acid secretion in rats.
Becker M; Sewing KF
J Pharm Pharmacol; 1971 Jun; 23(6):434-7. PubMed ID: 4397183
[No Abstract] [Full Text] [Related]
11. The effect of brocresine (NSD-1055) on the histidine decarboxylase activity in the rat gastric mucosa.
Mesch H; Sewing KF
J Pharm Pharmacol; 1971 Jul; 23(7):506-8. PubMed ID: 4397449
[No Abstract] [Full Text] [Related]
12. [Results of treatment of chronic urticaria, prurigo and pruritus with histaglobin].
Rudzki E; Czubalski K
Przegl Dermatol; 1967; 54(5):571-4. PubMed ID: 4383602
[No Abstract] [Full Text] [Related]
13. [Treatment of chronic prurigo with methdilazine (Tacryl)].
Gadborg E; Ludvigsen KE
Ugeskr Laeger; 1966 Jun; 128(24):706-8. PubMed ID: 4381504
[No Abstract] [Full Text] [Related]
14. Histamine synthesis and its inhibition in rabbit platelets in vitro.
Tuomisto J
Ann Med Exp Biol Fenn; 1970; 48(3):164-7. PubMed ID: 4394322
[No Abstract] [Full Text] [Related]
15. The effect of tritoqualine on anaphylactic and anaphylactoid shock in rats, evaluated by renal enzyme excretion studies.
Raab W
Med Exp Int J Exp Med; 1969; 19(5):301-11. PubMed ID: 4393124
[No Abstract] [Full Text] [Related]
16. [In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine)].
Carpi C; Maggi GC
Boll Soc Ital Biol Sper; 1968 Mar; 44(6):543-6. PubMed ID: 5674876
[No Abstract] [Full Text] [Related]
17. Studies on uptake and decarboxylation of histidine by isolated rat mast cells.
Cabut M; Haegermark O
Acta Physiol Scand; 1968; 73(1):62-74. PubMed ID: 4386195
[No Abstract] [Full Text] [Related]
18. [Action of an inhibitor of histidine decarboxylase on the liberation and reconstitution of cutaneous histamine in rats].
Grilliat JP; Laurent J; Noirel B; Arnould P
Rev Fr Allergol; 1966; 6(2):84-92. PubMed ID: 4161301
[No Abstract] [Full Text] [Related]
19. [Clinical study of the action of a histidine-decarboxylase inhibitor (L 554) on various allergic manifestations].
CASTELAIN PY
Mars Med; 1963; 100():121-9. PubMed ID: 14019175
[No Abstract] [Full Text] [Related]
20. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.
Bartholeyns J; Bouclier M
Cancer Res; 1984 Feb; 44(2):639-45. PubMed ID: 6692368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
